Xilio Therapeutics (Series B)

Funding Details

Awarder: Inbox
Date Award: March 02, 2020
Vertical: Biotechnology
Funding URL: View Funding Page
Funding Amount:: $100,500,000

Company Info

Founders: Rene Russo
Company Description: Xilio Therapeutics is a biotechnology company that develops tumor-activated immuno-oncology therapies.
Market: Cancer Immunotherapy
Location: Waltham, MA, USA
Coinvestors: Atlas Venture, Bay City Capital, F-Prime Capital Partners, Ipsen, M Ventures, MRL Ventures Fund, RiverVest Venture Partners, Solasta Ventures, SV Health Investors, Takeda Ventures

Links

Back to Home Back to Biotechnology Deals View Funding Announcement